Survival at one year in patients with lung cancer in a tertiary care center

  • Dr. Sreekala C Department of Pulmonary Medicine, Medical College, Thiruvananthapuram, Kerala, India
  • Dr. K. Anitha Kumari Department of Pulmonary Medicine, Medical College, Thiruvananthapuram, Kerala, India
  • Dr. Jayaprakash B Department of Pulmonary Medicine, Medical College, Thiruvananthapuram, Kerala, India
  • Dr. C Sudheendra Ghoshall Department of Pulmonary Medicine, Medical College, Thiruvananthapuram, Kerala, India
Keywords: Lung Cancer, Survival, Performance status (PS), Small cell cancer (SCC), Nonsmall lung cancer (NSCLC)

Abstract

Introduction: Lung cancer is a leading cause of mortality worldwide and despite advances in treatment, prognosis of advanced lung cancer is extremely poor, with a median survival time of approximately 1year. Factors like age, sex, performance status at the time of diagnosis, histological type, extent of disease, smoking status were found to predict survival in lung cancer.

Aim of the study: To determine one year survival of lung cancer patients from the date of diagnosis and to evaluate factors that are associated with survival.

Methodology: Prospective cohort study, conducted at Medical College, Thiruvananthapuram, Kerala, in 160 consecutive patients with histopathological diagnosis of lung cancer. Data on demography, symptoms, smoking status, performance status according to WHO performance scale, histological diagnosis, TNM stage and death were recorded using a structured questionnaire. Proportion of patients who survived at one year from the date of diagnosis was determined. For inferential statistics between groups, comparison of qualitative variables were analysed by chi-square test and quantitative variables were compared by student t test. P value of less than 0.05 was considered as level of significance Cox proportional hazard model were used to evaluate the factors affecting survival of lung cancer patients.

Results: 160 consecutive lung cancer patients with histopathological diagnosis were included in the study. 86.9% of patients were males. Male to Female ratio is 6.6: 1. 84. 5% of patients were above the age of 50 years. 11.3% were nonsmokers. COPD was the commonest comorbidity (58%) in the study. Adenocarcinoma (41.9%) was the commonest histological type in our study and this was the commonest histological type seen in females and nonsmokers. In smokers, squamous cell carcinoma (91.3%) was more common. 66.9% of patients were at TNM stage 3 or 4 at the time of diagnosis. 17.5% patients survived at one year after diagnosis. Age more than 70 years, high smoking index, associated COPD, TNM Stage 3 & 4, poor performance status at the time of diagnosis were associated with poor survival. (p value <0.001). Squamous cell carcinoma had better survival compared to other histological types (p< 0.001). No significant association between gender and survival pattern was seen in the study.

Conclusion: We found that 17.5% of lung cancer patients survived at one year after diagnosis. There was significant association of factors like age, smoking status, comorbidities, histological type, TNM stage and performance status at diagnosis with survival pattern. But no significant association between gender and survival was found in our study.

Downloads

Download data is not yet available.

References

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F.GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2014. Available from: http://globocan.iarc.fr. accessed on 16/01/2015.

Indian Council of Medical Research; 2013. [accessed on January 21, 2014]. National Cancer Registry Programme. Three Year Report of Population Based Cancer Registries: 2009-2011. Available from: http://www.ncrpindia.or

Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108.

Bhaskarapillai B, Kumar SS, Balasubramanian S. Lung cancer in Malabar Cancer Center in Kerala--a descriptive analysis. Asian Pac J Cancer Prev. 2012;13(9):4639-43.

Valaitis J, Warren S, Gamble D. Increasing incidence of adenocarcinoma of the lung. Cancer. 1981 Mar 1;47(5):1042-6.

Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe. Lung Cancer. 2003 Sep;41(3):245-58.

Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst. 2006 May 17;98(10):691-9.

Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D, Clarke CA, Holmberg L, Yong LC, Kolonel LN, Gould MK, West DW. Lung cancer incidence in never smokers. J Clin Oncol. 2007 Feb 10;25(5):472-8.

Behera D, Balamugesh T. Lung cancer in India. Indian J Chest Dis Allied Sci. 2004 Oct-Dec;46(4):269-81.

Singh N, Aggarwal AN, Gupta D, Behera D, Jindal SK. Unchanging clinico-epidemiological profile of lung cancer in north India over three decades. Cancer Epidemiol. 2010;34:101–4.

Noronha V, Dikshit R, Raut N, Joshi A, Pramesh CS, George K, Agarwal JP, Munshi A, Prabhash K. Epidemiology of lung cancer in India: focus on the differences between non-smokers and smokers: a single-centre experience. Indian J Cancer. 2012 Jan-Mar;49(1):74-81. doi: http://www.indianjcancer.com/text.asp?2012/49/1/74/98925.

Malik PS, Sharma MC, Mohanti BK, Shukla NK, Deo S, Mohan A, et al. Clinico-pathological profile of lung cancer at AIIMS: a changing paradigm in India. Asian Pac J Cancer Prev. 2013;14:489–94.

Skaug K, Eide GE, Gulsvik A. Predictors of long-term survival of lung cancer patients in a Norwegian community. Clin Respir J. 2011 Jan;5(1):50-8. doi: https://doi.org/10.1111/j.1752-699X.2010.00200.x.

Tas F, Ciftci R, Kilic L, Karabulut S. Age is a prognostic factor affecting survival in lung cancer patients. Oncol Lett. 2013 Nov;6(5):1507-1513. Epub 2013 Sep 6.

Kil Hoi Lee, Yunhyung Kwon, Tae Yong Lee. Survival Rate and Factors Affecting Survival among Patients of Lung Cancer Lived in Daejeon City. Korean Journal of Epidemiology 2003;25(2): 62-75.

Islam KM, Jiang X, Anggondowati T, Lin G, Ganti AK. Comorbidity and Survival in Lung Cancer Patients. Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1079-85. doi: https://doi.org/10.1158/1055-9965.EPI-15-0036. Epub 2015 Jun 11.

Karynsa Cetin, David S Ettinger, Yong-jiangHei, et al Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results ProgramClinEpidemiol. 2011; 3: 139–148.

Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest. 2004 Jan;125(1):27-37.

Lung Cancer Fact Sheet | American Lung Association 1-800-LUNGUSA. http://www.lung.org/lung-health-and.../lung-disease.../lung-cancer/.../lung-cancer-fact-sheet.

P.A. MaheshS. ArchanaB.S. Jayaraj ,ShekarPatil , S.K. Chaya , H.P. Shashidha, Sunitha:Factors affecting 30-month survival in lung cancer patients. Indian J of Med Res136 ,2012 pp614 -621.

Lee SJ, Lee J, Park YS, Lee CH, Lee SM, Yim JJ, Yoo CG, Han SK, Kim YW. Impact of smoking on mortality of patients with non-small cell lung cancer. Thorac Cancer. 2014 Jan;5(1):43-9. doi: https://doi.org/10.1111/1759-7714.12051. Epub 2014 Jan 2.

Survival at one year in patients with lung cancer in a tertiary care center
CITATION
DOI: 10.17511/ijmrr.2017.i04.01
Published: 2017-04-30
How to Cite
1.
C S, Kumari KA, B J, Ghoshall CS. Survival at one year in patients with lung cancer in a tertiary care center. Int J Med Res Rev [Internet]. 2017Apr.30 [cited 2024Nov.8];5(4):374-80. Available from: https://ijmrr.medresearch.in/index.php/ijmrr/article/view/853
Section
Original Article